The Benefits of a Connected Quality & Regulatory Ecosystem

August 6, 2024 |

1 min read |

Pictured from left to right: Lori Ellis - Head of Insights, BioSpace (Moderator), Sean McCarthy - VP of Regulatory Affairs, YourBio Health, Deepika A. Lakhani - PhD, Senior Vice President, Chief Regulatory & Quality Officer, Lucid Diagnostics, Sujat Sukthankar - Founder & CEO, RPD Advisors, Krystin Meidell - Director, Global Regulatory Strategy, Combination Products, AbbVie, Scott Kaplan - Deputy General Counsel, Baxter International Inc.

In this live panel discussion, speakers navigate integrated ecosystems and the future of QARA. An executive summary is available.

On July 23, 2024, regulatory compliance professionals from large and small medical device manufacturers, drug sponsors, law firms and Big Tech gathered in Boston to discuss AI’s influence on quality assurance and regulatory affairs (QARA) at a private event hosted by IQVIA Technologies.

The first panel discussion of the day was The Benefits of a Connected Quality & Regulatory Ecosystem with guests:

Sean McCarthy, VP of Regulatory Affairs, YourBio Health
Deepika A. Lakhani, PhD, Senior Vice President, Chief Regulatory & Quality Officer, Lucid Diagnostics
Sujat Sukthankar, Founder & CEO, RPD Advisors
Krystin Meidell, Director, Global Regulatory Strategy, Combination Products, AbbVie
Scott Kaplan, Deputy General Counsel, Baxter International Inc.
Lori Ellis, Head of Insights, BioSpace (Moderator)

Download complete Executive Summary:

Artificial intelligence Regulatory

Lori Ellis

Lori Ellis is the Head of Insights at BioSpace. She analyzes and comments on industry trends for BioSpace and clients. Her current focus is on the ever-evolving impact of technology on the pharmaceutical industry. You can reach her at lori.ellis@biospace.com. Follow her on LinkedIn.

BioSpace Insights

The BioSpace Insights teams performs research and analysis on industry trends for BioSpace and clients, producing industry reports, podcasts, events and articles.